Field of Interest. To support a specific interest of the Founder (e.g. Health, Arts, Environment etc.).
Field of Interest. The Field of Interest is hereby expanded to include:
Field of Interest. Section 14(j) of the Original Agreement (Miscellaneous) is hereby amended to delete the definition of Field of Interest in its entirety and to insert the following in its place:
Field of Interest. These types of funds allow you to support a specific area of interest that you care deeply about. You identify the area of charitable interest as broad or narrow as you choose – whether it's fostering the arts, providing support to underprivileged families, preserving the environment, investing in community development, giving to a specified geographical area, or any other worthwhile cause. The Community Foundation evaluates organizations that do the best work in the interest area, and then makes grants to the organizations that best fit your interest. This fund may be ideal for those who wish to rely on the Community Foundation’s expertise to make grants in their designated area of interest, as they need only to select their field of interest and the Community Foundation takes care of the rest. This fund is an excellent option for donors who wish to leave a legacy through an estate gift or bequest. Designated Funds: These type of funds enable you to choose or to continue supporting one or more specific charitable organizations to support. The Community Foundation will make grants only to the organizations you have chosen. Should the organization cease to exist or dramatically change, the Community Foundation will direct your grants to one or more organizations that most closely honor your intent. This fund is also an excellent option for donors who wish to leave a legacy through an estate gift or bequest.
Field of Interest. As used herein, the term "Field of Interest" means the research of, and/or the development, manufacture and sale of, any therapeutic or diagnostic product that is developed, manufactured or sold by the Company at any time during the Term, as documented in the bi-weekly scientific project reports or other scientific planning documents of the company (the "Scientific Reports") prepared by the Company during the Term. You hereby acknowledge and agree that the Field of Interest shall be assessed for purposes of this Agreement as of the date on which your employment with the Company terminates, which assessment shall include, without limitation, a review of the applicable Scientific Reports.
Field of Interest. Award of grants from the Fund shall be made to those qualified applicants who provide services in the following field of interest: (Example: Arts, Education, Safety Net Services, etc.)
Field of Interest. Executive recognizes and acknowledges the competitive and proprietary nature of the Corporation’s business operations. Executive acknowledges and agrees that a business will be deemed competitive with the Corporation if it provides products or services related to the current or proposed products or services, or information now or hereafter provided or offered by the Corporation or under development by the Corporation that are in the Corporation’s “Field of Interest.” For purpose of clarity, the Corporation’s Field of Interest is the discovery, development, commercialization and marketing of therapeutics (i) based on kinase inhibitors discovered through Mimetica and OPAL, (ii) pre-tubulin polymerization inhibitors, small molecules against OraA1, or (iv) P-glycoprotein inhibitors based on HM30181A for enhanced oral absorption.
Field of Interest. Cancer therapy in humans wherein paclitaxel is delivered in liposomes, lipid complexes, or other liposome particles, to the respiratory tract via aqueous aerosol droplets. EXHIBIT B Work Plan The attachment titled “Paclitaxel Liposome Aerosol Research Plan” describes the work plan and is incorporated by reference herein. EXHIBIT C
Field of Interest. Cancer therapy in humans wherein 9-nitro-camptothecin is delivered in liposomes, lipid complexes, or other liposome particles, to the respiratory tract via aqueous aerosol droplets. EXHIBIT B Work Plan The attachment titled “9-Nitrocamptothecin Liposome Aerosol Research Plan” describes the work plan and is incorporated by reference herein. EXHIBIT C
Field of Interest. The term "Field of Interest" shall mean Commercial Sale of Limited Through-Put products for research, development, analytical or manufacturing Applications, including [ * ] but not other Diagnostic Products, and excluding [ * ], which products are designed (i) to introduce and prepare chemical, biochemical and biological samples, (ii) to perform assays, synthesis and other reactions, or (iii) to perform physical separations and detection. [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
